Anchiano Therapeutics Ltd (ANCN:NASDAQ) jumped higher at $2.88, a gain of 87%. On Mon 14 Dec 20, ANCN:NASDAQ touched a New 2-Week Intraday High of $1.71. The stock got featured on our News Catalysts scanner on Tue 15 Dec 20 at 12:24 PM in the 'AGREEMENT' category. From Mon 30 Nov 20, the stock recorded 60.00% Up Days and 27.27% Green Days
The stock spiked on Thu 05 Nov 20 at $2.72 with a volume of 8M+, and its share price has been moving sideways in recent weeks.
About Anchiano Therapeutics Ltd (ANCN:NASDAQ)
Anchiano Therapeutics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel therapies to treat cancer in areas of unmet need.
Top 10 Gainers:
- Concord Medical Services Holdings Limited (CCM:NYSE), 179.46%
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 87.01%
- Prevail Therapeutics Inc. (PRVL:NASDAQ), 82%
- MicroVision, Inc. (MVIS:NASDAQ), 34.5%
- ELYS (ELYS:NASDAQ), 29.03%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 27.62%
- Arvinas, Inc. (ARVN:NASDAQ), 27.18%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 26.66%
- Sensus Healthcare, Inc. (SRTS:NASDAQ), 26.4%
- Solid Biosciences Inc. (SLDB:NASDAQ), 23.38%